首页> 外国专利> HUMAN APOLIPOPROTEIN AI

HUMAN APOLIPOPROTEIN AI

机译:human AP OL IPO protein AI

摘要

An expression vector capable of expressing, in a transformed host, a protein which is capable of being detected by ELISA with anti-human apoAI antiserum and which has the formula (1) Met-X-Y (1) wherein X is a b ond, a carrier peptide sequence which comprises a sequence derived from the N-terminal amino acid residues of beta-galactosidase or a sequence comprising one or more IgG-binding domains of Protein A, or the pro sequence of human apoAI; and Y represents the sequence of human apoAI or a genetic variant thereof. Hosts transformed with such vectors produce the protein, which is useful in the treatment of atherosclerosis and cardiovascular diseases.
机译:一种表达载体,其能够在转化的宿主中表达能够通过抗人apoAI抗血清通过ELISA检测并且具有式(1)Met-XY(1)(其中X为旁)的蛋白质的载体肽序列,其包含衍生自β-半乳糖苷酶的N-末端氨基酸残基的序列或包含蛋白A的一个或多个IgG结合结构域的序列,或人apoAI的前序列; Y代表人apoAI或其遗传变异体的序列。用这种载体转化的宿主产生该蛋白,该蛋白可用于治疗动脉粥样硬化和心血管疾病。

著录项

  • 公开/公告号GB8625435D0

    专利类型

  • 公开/公告日1986-11-26

    原文格式PDF

  • 申请/专利权人 FARMITALIA CARLO ERBA SPA;

    申请/专利号GB19860025435

  • 发明设计人

    申请日1986-10-23

  • 分类号C12N15/09;A61K38;A61P9/10;C07K14;C07K14/195;C07K14/31;C07K14/41;C07K14/435;C07K14/775;C07K19;C12N1/20;C12N1/21;C12N15/62;C12N15/70;C12P21/02;C12R1/19;

  • 国家 GB

  • 入库时间 2022-08-22 07:10:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号